Larimar Therapeutics (LRMR) Q3 2026 Earnings Report

1,155 Followers

LRMR Upcoming Earnings

Larimar Therapeutics's next earnings date is estimated for March 19, 2027, based on past reporting schedules.

Q3 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

LRMR earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 19, 2027	2026 (Q4)	―-	-0.73	―	―
Nov 05, 2026	2026 (Q3)	-0.35-	-0.61	―
Aug 04, 2026	2026 (Q2)	-0.38-0.30	-0.41	26.83% (+0.11)
May 14, 2026	2026 (Q1)	-0.54-0.31	-0.46	32.61% (+0.15)
Mar 19, 2026	2025 (Q4)	-0.49-0.73	-0.45	-62.22% (-0.28)
Nov 05, 2025	2025 (Q3)	-0.40-0.61	-0.24	-154.17% (-0.37)
Aug 14, 2025	2025 (Q2)	-0.48-0.41	-0.34	-20.59% (-0.07)
Apr 30, 2025	2025 (Q1)	-0.42-0.46	-0.27	-70.37% (-0.19)
Mar 24, 2025	2024 (Q4)	-0.32-0.45	-0.3	-50.00% (-0.15)
Oct 30, 2024	2024 (Q3)	-0.38-0.24	-0.21	-14.29% (-0.03)
Aug 07, 2024	2024 (Q2)	-0.30-0.34	-0.19	-78.95% (-0.15)
May 09, 2024	2024 (Q1)	-0.24-0.27	-0.15	-80.00% (-0.12)
Mar 14, 2024	2023 (Q4)	-0.25-0.30	-0.21	-42.86% (-0.09)
Nov 14, 2023	2023 (Q3)	-0.22-0.21	-0.37	43.24% (+0.16)
Aug 10, 2023	2023 (Q2)	-0.20-0.19	-0.47	59.57% (+0.28)
May 15, 2023	2023 (Q1)	-0.25-0.15	-0.49	69.39% (+0.34)
Mar 14, 2023	2022 (Q4)	-0.37-0.21	-0.5	58.00% (+0.29)
Nov 10, 2022	2022 (Q3)	-0.42-0.37	-0.92	59.78% (+0.55)
Aug 11, 2022	2022 (Q2)	-0.57-0.47	-0.79	40.51% (+0.32)
May 12, 2022	2022 (Q1)	-0.58-0.49	-0.76	35.53% (+0.27)
Mar 25, 2022	2021 (Q4)	-0.72-0.50	-0.89	43.82% (+0.39)
Nov 12, 2021	2021 (Q3)	-0.64-0.92	-0.64	-43.75% (-0.28)
Aug 12, 2021	2021 (Q2)	-0.75-0.79	-1.21	34.71% (+0.42)
May 10, 2021	2021 (Q1)	―-0.76	-1.15	34.03% (+0.39)
Mar 04, 2021	2020 (Q4)	―-0.89	-2.28	60.96% (+1.39)
Nov 10, 2020	2020 (Q3)	―-0.64	-4.2	84.76% (+3.56)
Aug 11, 2020	2020 (Q2)	―-1.21	-3.84	68.49% (+2.63)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed